Loteo

Loteo

ICO Ended
6,892 Views
Loteo is digital automated lottery platform that uses blockchain and smart contracts to create a fully transparent lottery, where your chances are incomparably higher compared to conventional lotteries.

LOTES is a security token which is meant to be sold only in private funding round (the STO). There will not be any public sale, for all investment requirements, please fill the form on the website www.playloteo.com. This token grants owners an opportunity to profit from being part of a lottery without being attendees in amount 20% of each prize total value. The LOTES are locked for 15 months and during this time it is not possible to buy or sell them anywhere else. After the first 15 months pass, there will be another funding round during which LOTEO will sell at least 30% of all tokens in compliance with legal and regulatory requirements. All details will be revealed before this event. After selling these tokens, the token will be listed on exchanges. After 15 months,maximum 20% of all security tokens will be owned by the lottery while 80% will be decentralized, preventing the lottery from being manipulated. The token also has a governing function, meaning any significant change has to be achieved by consensus and any token holder can issue a suggestion or voting.
6.8
TOTAL SCORE
7.7
ICO PROFILE

(weight: 45%)

1
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
ICO Time: 01 Mar 2019 - 30 Apr 2019
Whitelist/KYC: KYC
Country: Curaçao
Token info
Ticker: LOTES
Platform: Ethereum
Token Type: ERC827
Financial
ICO Price: 1 LOTES = 0.05 EUR
Accepting: BTC, ETH, EUR
Soft cap: 1,500,000 EUR
Hard cap: 2,500,000 EUR
Q1 2019
Legal.<br /> <br /> Project funding.<br /> <br /> Testing weekly lottery.<br /> <br /> 31/3 MVP ready.<br /> <br /> 31/3 WEB starts.<br />
Q2 2019
Bug bounty.<br /> <br /> Soft launch 1/5.<br /> <br /> Hard launch 1/6 .<br /> <br /> Promo campaign.<br /> <br /> BTC payment available.
Q3 2019
Launch Daily lottery.<br /> <br /> Card payment.<br /> <br /> Mobile message payments locally.
Q4 2019
Launch of 3rd game.<br /> <br /> Mobile message payments spreading.
Q1 2020
iOS & Android app.<br /> <br /> Special announcement.
Q3 2020
External API integration.<br /> <br /> LOTES unlock, 2nd PS round.<br /> <br /> LOTEO games.
Q4 2020
LOTES exchange listing.
2021
LOTEO Bets - P2P Bets system.<br /> <br /> LOTEO Tickets available throught 3rd parties.
2022
LOTEO B2B Platform.
Screenshots taken on 22 Mar 2019
Rastislav Bakala
CEO, co-founder
No participating data
Jan Lalka
CFO, co-founder
No participating data
Juraj Illes
CMO, co-founder
No participating data
Rene Darmos
CBDO, co-founder
No participating data
Nina Bakalova
PR manager
No participating data
Julius Buchel
Community manager
No participating data

Advisors (2)

Max Zakomoldin
Sales advisor
No participating data
Robert Auxt
Legal & Exchange advisor
No participating data
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Active
Rivalz
Rivalz is redefining AI infrastructure by creating an AI Intel Layer to unlock new agentic economies. Built on a dual-chain DePIN architecture using Dymension and Arbitrum, Rivalz addresses one of the biggest bottlenecks in AI today: access to AI-ready, verifiable, and secure data. As we envision the web3 space to become agentic and overtake humans in the amount of transactions over time, what Rivalz is building is key for enabling this future. The core challenge that Rivalz is addressing is the need for AI-ready, verifiable and accessible data and later on intelligence. Rivalz offers a hybrid solution combining decentralized storage and high-speed agent-centric connectivity networks that cater specifically to AI's demands, ushering in the era of the agentic economy.
Upcoming
DINNGO
The first exchange to enable simple two step verification with mobile device and cold wallet. Dinngo is revolutionising the way we trade digital currencies. Our cold wallet integrates seamlessly with the Dinngo exchange, providing the secure, fast and convenient asset trading service the market needs.
Upcoming
MeFy
Mefy works on a subscription-based model, where the user of MeMe Care subscribes for yearly subscription allowing them any number of tests throughout the year for the cost of just consumables. Through its eConsult feature it connects worldwide doctors to worldwide patients thereby resolving accessibility issues and with its MeMe Edge device, it provides authenticity to the test conducted.
Upcoming
Talao
Talao is the first Ethereum-based DAO for Talent, which introduces a unique way for users to own their data thanks to a secure digital vault storing their certificates on the blockchain. Talao provides a decentralized marketplace, governed by Talent, on which neither intermediaries nor commissions apply.
Upcoming
Crypto Potential
Crypto badges. Simple. Rewarding. Transparent. Incentivizing achievements through dedicated crypto badges. Blockchain projects are evaluated and tested for specific parameters and awarded with badges according to their achievements and contribution. The badges stand for credibility and transparency and serve to incentivize qualified projects with QCP token. The Crypto-Potential community will have access to a selection of projects with verified information and their achievements. The mission is to empower projects to achieve more. The vision is to create a more transparent crypto space.
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.